article · Journal of the International AIDS Society
CAB-LA concentrations post-cessation of injections were generally well tolerated in pregnant women. The t<sub>1/2app</sub> was comparable between pregnant and non-pregnant women. Ongoing studies will examine the safety and pharmacology of CAB-LA in women who choose to continue CAB-LA through pregnancy and lactation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/jia2.26401
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
